Oral Dydrogesterone in the Management of Preterm Labor

• Status: Completed
• Trial end date: 2020-05-31
• Target enrollment: 0
• Participant gender: Female

Summary

This study evaluates the addition of oral dydrogesterone to standard treatment in the treatment of preterm labor. Half of participants will receive oral dydrogesterone and standard treatment, while the other half will receive oral placebo and standard treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Chulalongkorn University
• Treatments: Dydrogesterone

Criteria

Inclusion Criteria:

• singleton pregnancy with gestational age 24-33 weeks 6 days

• preterm labor

• received treatment with tocolysis and corticosteroids

Exclusion Criteria:

• conditions that need immediate delivery such as fetal distress, chorioamnionitis

• have medical complications such as heart disease, seizure

• fetal anomalies

• cervical dilatation more than 5 cm

• allergy to dydrogesterone